Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$62M |
 |
Mind Medicine (MindMed)MNMD |
-$44M |
 |
ModernaMRNA |
-$256B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Litchfield Caroline | Feb 14, 2024 | Sell | 38,291 | $125.5 | $4.8M |
| Davis Robert M | Feb 14, 2024 | Sell | 85,021 | $125.3993 | $11M |
| Davis Robert M | Feb 13, 2024 | Sell | 124,676 | $125.7431 | $16M |
| Davis Robert M | Feb 13, 2024 | Sell | 25,324 | $126.3733 | $3.2M |
| Romanelli Joseph | Feb 13, 2024 | Sell | 1,000 | $124.8879 | $120,000 |
| Li Dean Y | Feb 9, 2024 | Sell | 14,702 | $125.4988 | $1.8M |
| Williams David Michael | Feb 7, 2024 | Sell | 1,451 | $127.5729 | $190,000 |
| Oosthuizen Johannes Jacobus | Feb 2, 2024 | Sell | 18,959 | $127.175 | $2.4M |
| MIZELL STEVEN | Feb 2, 2024 | Sell | 50,694 | $126.6491 | $6.4M |
| Zachary Jennifer | Feb 2, 2024 | Sell | 49,499 | $126.9678 | $6.3M |
| Oosthuizen Johannes Jacobus | Nov 9, 2023 | Sell | 2,081 | $102.3841 | $210,000 |
| DeLuca Richard R. | Nov 8, 2023 | Sell | 43,823 | $105.0286 | $4.6M |
| MIZELL STEVEN | Aug 14, 2023 | Sell | 4,250 | $109.01 | $460,000 |
| MIZELL STEVEN | Aug 3, 2023 | Sell | 4,500 | $105.4891 | $470,000 |
| Romanelli Joseph | Aug 2, 2023 | Sell | 59 | $107.371 | $6,300 |
| Romanelli Joseph | Aug 2, 2023 | Sell | 30 | $107.371 | $3,200 |
| Zachary Jennifer | May 4, 2023 | Sell | 19,141 | $117.5923 | $2.3M |
| Karachun Rita A | May 4, 2023 | Sell | 15,875 | $117.5334 | $1.9M |
| MIZELL STEVEN | May 3, 2023 | Sell | 15,000 | $119.0081 | $1.8M |
| MIZELL STEVEN | May 3, 2023 | Sell | 13,400 | $119.01 | $1.6M |
| MIZELL STEVEN | May 3, 2023 | Sell | 13,000 | $119.0086 | $1.5M |
| MIZELL STEVEN | May 3, 2023 | Sell | 12,000 | $119.0074 | $1.4M |
| Williams David Michael | May 2, 2023 | Sell | 7,509 | $116.8228 | $880,000 |
| DeLuca Richard R. | May 1, 2023 | Sell | 75,436 | $116.0288 | $8.8M |
| Davis Robert M | Apr 28, 2023 | Sell | 143,329 | $114.9303 | $16M |
| DeLuca Richard R. | Apr 28, 2023 | Sell | 66,163 | $115.0015 | $7.6M |
| Romanelli Joseph | Apr 26, 2023 | Buy | 3 | $113.68 | $340 |
| Chattopadhyay Sanat | Apr 13, 2023 | Sell | 67,892 | $115.0705 | $7.8M |
| Chattopadhyay Sanat | Apr 13, 2023 | Sell | 66,163 | $115.0598 | $7.6M |
| Romanelli Joseph | Mar 24, 2023 | Sell | 35 | $104.65 | $3,700 |
| Romanelli Joseph | Mar 20, 2023 | Buy | 136 | $105.47 | $14,000 |
| Romanelli Joseph | Feb 21, 2023 | Buy | 11 | $109.2 | $1,200 |
| Romanelli Joseph | Feb 15, 2023 | Sell | 5,000 | $108.2201 | $540,000 |
| MIZELL STEVEN | Feb 13, 2023 | Sell | 1,815 | $109.1003 | $200,000 |
| MIZELL STEVEN | Feb 9, 2023 | Sell | 5,000 | $107.0013 | $540,000 |
| MIZELL STEVEN | Feb 6, 2023 | Sell | 4,436 | $104.2546 | $460,000 |
| Zachary Jennifer | Feb 3, 2023 | Sell | 75,436 | $103.1704 | $7.8M |
| Chattopadhyay Sanat | Jan 9, 2023 | Sell | 38,216 | $113.7752 | $4.3M |
| Chattopadhyay Sanat | Jan 9, 2023 | Sell | 35,598 | $110.6146 | $3.9M |
| Chattopadhyay Sanat | Jan 9, 2023 | Sell | 4,538 | $111.7339 | $510,000 |
| Chattopadhyay Sanat | Jan 9, 2023 | Sell | 3,940 | $112.7823 | $440,000 |
| Chattopadhyay Sanat | Jan 9, 2023 | Sell | 1,702 | $114.4612 | $190,000 |
What's the latest insider transaction for Merck & Company?
The most recent insider transaction for Merck & Company was conducted by Litchfield Caroline, who sold 38,291 shares on February 14, 2024 at a price of $125.50 per share.
Which insider bought the most MRK stock over the last two years?
Romanelli Joseph has bought the most MRK stock in the last 2 years, with a total value of $16,000.
Which insider has sold the most MRK stock over the last two years?
Davis Robert M has sold the most MRK stock in the last 2 years, with a total value of $46M.
What is the total value of insider transactions for Merck & Company (MRK) in the last 2 years?
The total value of insider transactions for Merck & Company in the last 2 years is negative, amounting to -$136M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Merck & Company's market confidence?
Over the last 2 years, insider transactions for Merck & Company have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
